Table of Content

1 Tourette Syndrome Drug Market Overview
1.1 Tourette Syndrome Drug Product Scope
1.2 Tourette Syndrome Drug Segment by Type
1.2.1 Global Tourette Syndrome Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 AZD-5213
1.2.3 CPP-115
1.2.4 Dutetrabenazine ER
1.2.5 Ecopipam Hydrochloride
1.2.6 Others
1.3 Tourette Syndrome Drug Segment by Application
1.3.1 Global Tourette Syndrome Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Tourette Syndrome Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Tourette Syndrome Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Tourette Syndrome Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Tourette Syndrome Drug Price Trends (2016-2027)

2 Tourette Syndrome Drug Estimates and Forecasts by Region
2.1 Global Tourette Syndrome Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Tourette Syndrome Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Tourette Syndrome Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Tourette Syndrome Drug Revenue Market Share by Region (2016-2021)
2.3 Global Tourette Syndrome Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Tourette Syndrome Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Tourette Syndrome Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Tourette Syndrome Drug Estimates and Projections (2016-2027)
2.4.2 Europe Tourette Syndrome Drug Estimates and Projections (2016-2027)
2.4.3 China Tourette Syndrome Drug Estimates and Projections (2016-2027)
2.4.4 Japan Tourette Syndrome Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Tourette Syndrome Drug Estimates and Projections (2016-2027)
2.4.6 India Tourette Syndrome Drug Estimates and Projections (2016-2027)

3 Global Tourette Syndrome Drug Competition Landscape by Players
3.1 Global Top Tourette Syndrome Drug Players by Sales (2016-2021)
3.2 Global Top Tourette Syndrome Drug Players by Revenue (2016-2021)
3.3 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tourette Syndrome Drug as of 2020)
3.4 Global Tourette Syndrome Drug Average Price by Company (2016-2021)
3.5 Manufacturers Tourette Syndrome Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Tourette Syndrome Drug Market Size by Type
4.1 Global Tourette Syndrome Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Tourette Syndrome Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Tourette Syndrome Drug Price by Type (2016-2021)
4.2 Global Tourette Syndrome Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Tourette Syndrome Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Tourette Syndrome Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Tourette Syndrome Drug Price Forecast by Type (2022-2027)

5 Global Tourette Syndrome Drug Market Size by Application
5.1 Global Tourette Syndrome Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Tourette Syndrome Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Tourette Syndrome Drug Price by Application (2016-2021)
5.2 Global Tourette Syndrome Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Tourette Syndrome Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Tourette Syndrome Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Tourette Syndrome Drug Price Forecast by Application (2022-2027)

6 North America Tourette Syndrome Drug Market Facts & Figures
6.1 North America Tourette Syndrome Drug Sales by Company
6.1.1 North America Tourette Syndrome Drug Sales by Company (2016-2021)
6.1.2 North America Tourette Syndrome Drug Revenue by Company (2016-2021)
6.2 North America Tourette Syndrome Drug Sales Breakdown by Type
6.2.1 North America Tourette Syndrome Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Tourette Syndrome Drug Sales Breakdown by Type (2022-2027)
6.3 North America Tourette Syndrome Drug Sales Breakdown by Application
6.3.1 North America Tourette Syndrome Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Tourette Syndrome Drug Sales Breakdown by Application (2022-2027)

7 Europe Tourette Syndrome Drug Market Facts & Figures
7.1 Europe Tourette Syndrome Drug Sales by Company
7.1.1 Europe Tourette Syndrome Drug Sales by Company (2016-2021)
7.1.2 Europe Tourette Syndrome Drug Revenue by Company (2016-2021)
7.2 Europe Tourette Syndrome Drug Sales Breakdown by Type
7.2.1 Europe Tourette Syndrome Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Tourette Syndrome Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Tourette Syndrome Drug Sales Breakdown by Application
7.3.1 Europe 118 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 118 Sales Breakdown by Application (2022-2027)

8 China Tourette Syndrome Drug Market Facts & Figures
8.1 China Tourette Syndrome Drug Sales by Company
8.1.1 China Tourette Syndrome Drug Sales by Company (2016-2021)
8.1.2 China Tourette Syndrome Drug Revenue by Company (2016-2021)
8.2 China Tourette Syndrome Drug Sales Breakdown by Type
8.2.1 China Tourette Syndrome Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Tourette Syndrome Drug Sales Breakdown by Type (2022-2027)
8.3 China Tourette Syndrome Drug Sales Breakdown by Application
8.3.1 China 142 Sales Breakdown by Application (2016-2021)
8.3.2 China 142 Sales Breakdown by Application (2022-2027)

9 Japan Tourette Syndrome Drug Market Facts & Figures
9.1 Japan Tourette Syndrome Drug Sales by Company
9.1.1 Japan Tourette Syndrome Drug Sales by Company (2016-2021)
9.1.2 Japan Tourette Syndrome Drug Revenue by Company (2016-2021)
9.2 Japan Tourette Syndrome Drug Sales Breakdown by Type
9.2.1 Japan Tourette Syndrome Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Tourette Syndrome Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Tourette Syndrome Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Tourette Syndrome Drug Market Facts & Figures
10.1 Southeast Asia Tourette Syndrome Drug Sales by Company
10.1.1 Southeast Asia Tourette Syndrome Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Tourette Syndrome Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Tourette Syndrome Drug Sales Breakdown by Type
10.2.1 Southeast Asia Tourette Syndrome Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Tourette Syndrome Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Tourette Syndrome Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Tourette Syndrome Drug Market Facts & Figures
11.1 India Tourette Syndrome Drug Sales by Company
11.1.1 India Tourette Syndrome Drug Sales by Company (2016-2021)
11.1.2 India Tourette Syndrome Drug Revenue by Company (2016-2021)
11.2 India Tourette Syndrome Drug Sales Breakdown by Type
11.2.1 India Tourette Syndrome Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Tourette Syndrome Drug Sales Breakdown by Type (2022-2027)
11.3 India Tourette Syndrome Drug Sales Breakdown by Application
11.3.1 India Tourette Syndrome Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Tourette Syndrome Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Tourette Syndrome Drug Business
12.1 Abide Therapeutics Inc
12.1.1 Abide Therapeutics Inc Corporation Information
12.1.2 Abide Therapeutics Inc Business Overview
12.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
12.1.5 Abide Therapeutics Inc Recent Development
12.2 Catalyst Pharmaceuticals Inc
12.2.1 Catalyst Pharmaceuticals Inc Corporation Information
12.2.2 Catalyst Pharmaceuticals Inc Business Overview
12.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.2.5 Catalyst Pharmaceuticals Inc Recent Development
12.3 Neurocrine Biosciences Inc
12.3.1 Neurocrine Biosciences Inc Corporation Information
12.3.2 Neurocrine Biosciences Inc Business Overview
12.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Products Offered
12.3.5 Neurocrine Biosciences Inc Recent Development
12.4 Psyadon Pharmaceuticals Inc
12.4.1 Psyadon Pharmaceuticals Inc Corporation Information
12.4.2 Psyadon Pharmaceuticals Inc Business Overview
12.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.4.5 Psyadon Pharmaceuticals Inc Recent Development
12.5 Reviva Pharmaceuticals Inc
12.5.1 Reviva Pharmaceuticals Inc Corporation Information
12.5.2 Reviva Pharmaceuticals Inc Business Overview
12.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.5.5 Reviva Pharmaceuticals Inc Recent Development
12.6 Synchroneuron Inc
12.6.1 Synchroneuron Inc Corporation Information
12.6.2 Synchroneuron Inc Business Overview
12.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Synchroneuron Inc Tourette Syndrome Drug Products Offered
12.6.5 Synchroneuron Inc Recent Development
12.7 Teva Pharmaceutical Industries Ltd
12.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd Business Overview
12.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd Recent Development
12.8 Therapix Biosciences Ltd
12.8.1 Therapix Biosciences Ltd Corporation Information
12.8.2 Therapix Biosciences Ltd Business Overview
12.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Products Offered
12.8.5 Therapix Biosciences Ltd Recent Development

13 Tourette Syndrome Drug Manufacturing Cost Analysis
13.1 Tourette Syndrome Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tourette Syndrome Drug
13.4 Tourette Syndrome Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tourette Syndrome Drug Distributors List
14.3 Tourette Syndrome Drug Customers

15 Market Dynamics
15.1 Tourette Syndrome Drug Market Trends
15.2 Tourette Syndrome Drug Drivers
15.3 Tourette Syndrome Drug Market Challenges
15.4 Tourette Syndrome Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tourette Syndrome Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Tourette Syndrome Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Tourette Syndrome Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Tourette Syndrome Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Tourette Syndrome Drug Sales Market Share by Region (2016-2021)
Table 6. Global Tourette Syndrome Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Tourette Syndrome Drug Revenue Share by Region (2016-2021)
Table 8. Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Tourette Syndrome Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Tourette Syndrome Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Tourette Syndrome Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Tourette Syndrome Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Tourette Syndrome Drug Sales Share by Company (2016-2021)
Table 14. Global Tourette Syndrome Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Tourette Syndrome Drug Revenue Share by Company (2016-2021)
Table 16. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tourette Syndrome Drug as of 2020)
Table 17. Global Tourette Syndrome Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Tourette Syndrome Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Tourette Syndrome Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Tourette Syndrome Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Tourette Syndrome Drug Sales Share by Type (2016-2021)
Table 23. Global Tourette Syndrome Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Tourette Syndrome Drug Sales Share by Type (2022-2027)
Table 26. Global Tourette Syndrome Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Tourette Syndrome Drug Revenue Share by Type (2022-2027)
Table 28. Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Tourette Syndrome Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Tourette Syndrome Drug Sales Share by Application (2016-2021)
Table 31. Global Tourette Syndrome Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Tourette Syndrome Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Tourette Syndrome Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Tourette Syndrome Drug Sales Share by Application (2022-2027)
Table 35. Global Tourette Syndrome Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Tourette Syndrome Drug Revenue Share by Application (2022-2027)
Table 37. Global Tourette Syndrome Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Tourette Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Tourette Syndrome Drug Sales Market Share by Company (2016-2021)
Table 40. North America Tourette Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Tourette Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Tourette Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
Table 44. North America Tourette Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Tourette Syndrome Drug Sales Market Share by Type (2022-2027)
Table 46. North America Tourette Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
Table 48. North America Tourette Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Tourette Syndrome Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Tourette Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Tourette Syndrome Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Tourette Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Tourette Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Tourette Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Tourette Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Tourette Syndrome Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Tourette Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Tourette Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Tourette Syndrome Drug Sales Market Share by Application (2022-2027)
Table 62. China Tourette Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Tourette Syndrome Drug Sales Market Share by Company (2016-2021)
Table 64. China Tourette Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Tourette Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 66. China Tourette Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
Table 68. China Tourette Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Tourette Syndrome Drug Sales Market Share by Type (2022-2027)
Table 70. China Tourette Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
Table 72. China Tourette Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Tourette Syndrome Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Tourette Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Tourette Syndrome Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Tourette Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Tourette Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Tourette Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Tourette Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Tourette Syndrome Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Tourette Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Tourette Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Tourette Syndrome Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Tourette Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Tourette Syndrome Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Tourette Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Tourette Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Tourette Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Tourette Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Tourette Syndrome Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Tourette Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Tourette Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Tourette Syndrome Drug Sales Market Share by Application (2022-2027)
Table 98. India Tourette Syndrome Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Tourette Syndrome Drug Sales Market Share by Company (2016-2021)
Table 100. India Tourette Syndrome Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Tourette Syndrome Drug Revenue Market Share by Company (2016-2021)
Table 102. India Tourette Syndrome Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
Table 104. India Tourette Syndrome Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Tourette Syndrome Drug Sales Market Share by Type (2022-2027)
Table 106. India Tourette Syndrome Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
Table 108. India Tourette Syndrome Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Tourette Syndrome Drug Sales Market Share by Application (2022-2027)
Table 110. Abide Therapeutics Inc Corporation Information
Table 111. Abide Therapeutics Inc Description and Business Overview
Table 112. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Abide Therapeutics Inc Tourette Syndrome Drug Product
Table 114. Abide Therapeutics Inc Recent Development
Table 115. Catalyst Pharmaceuticals Inc Corporation Information
Table 116. Catalyst Pharmaceuticals Inc Description and Business Overview
Table 117. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 119. Catalyst Pharmaceuticals Inc Recent Development
Table 120. Neurocrine Biosciences Inc Corporation Information
Table 121. Neurocrine Biosciences Inc Description and Business Overview
Table 122. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Neurocrine Biosciences Inc Tourette Syndrome Drug Product
Table 124. Neurocrine Biosciences Inc Recent Development
Table 125. Psyadon Pharmaceuticals Inc Corporation Information
Table 126. Psyadon Pharmaceuticals Inc Description and Business Overview
Table 127. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 129. Psyadon Pharmaceuticals Inc Recent Development
Table 130. Reviva Pharmaceuticals Inc Corporation Information
Table 131. Reviva Pharmaceuticals Inc Description and Business Overview
Table 132. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 134. Reviva Pharmaceuticals Inc Recent Development
Table 135. Synchroneuron Inc Corporation Information
Table 136. Synchroneuron Inc Description and Business Overview
Table 137. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Synchroneuron Inc Tourette Syndrome Drug Product
Table 139. Synchroneuron Inc Recent Development
Table 140. Teva Pharmaceutical Industries Ltd Corporation Information
Table 141. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 142. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product
Table 144. Teva Pharmaceutical Industries Ltd Recent Development
Table 145. Therapix Biosciences Ltd Corporation Information
Table 146. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Therapix Biosciences Ltd Description and Business Overview
Table 148. Therapix Biosciences Ltd Tourette Syndrome Drug Product
Table 149. Therapix Biosciences Ltd Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Tourette Syndrome Drug Distributors List
Table 153. Tourette Syndrome Drug Customers List
Table 154. Tourette Syndrome Drug Market Trends
Table 155. Tourette Syndrome Drug Market Drivers
Table 156. Tourette Syndrome Drug Market Challenges
Table 157. Tourette Syndrome Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Tourette Syndrome Drug Product Picture
Figure 2. Global Tourette Syndrome Drug Sales Market Share by Type in 2021 & 2027
Figure 3. AZD-5213 Product Picture
Figure 4. CPP-115 Product Picture
Figure 5. Dutetrabenazine ER Product Picture
Figure 6. Ecopipam Hydrochloride Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tourette Syndrome Drug Sales Market Share by Application in 2021 & 2027
Figure 9. Research Center Examples
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Tourette Syndrome Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Tourette Syndrome Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Tourette Syndrome Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 16. Global Tourette Syndrome Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 17. Global Tourette Syndrome Drug Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Tourette Syndrome Drug Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Tourette Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Tourette Syndrome Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 21. Europe Tourette Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Tourette Syndrome Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Tourette Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Tourette Syndrome Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Tourette Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Tourette Syndrome Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Tourette Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Tourette Syndrome Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Tourette Syndrome Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Tourette Syndrome Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Tourette Syndrome Drug Players Market Share by Revenue in Tourette Syndrome Drug: 2016 & 2020
Figure 32. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Tourette Syndrome Drug Revenue Share by Type (2016-2021)
Figure 34. Global Tourette Syndrome Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Tourette Syndrome Drug Revenue Share by Application (2016-2021)
Figure 36. Global Tourette Syndrome Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Tourette Syndrome Drug Sales Market Share by Type in 2020
Figure 38. North America Tourette Syndrome Drug Sales Market Share by Application in 2020
Figure 39. Europe Tourette Syndrome Drug Sales Market Share by Type in 2020
Figure 40. Europe Tourette Syndrome Drug Sales Market Share by Application in 2020
Figure 41. China Tourette Syndrome Drug Sales Market Share by Type in 2020
Figure 42. China Tourette Syndrome Drug Sales Market Share by Application in 2020
Figure 43. Japan Tourette Syndrome Drug Sales Market Share by Type in 2020
Figure 44. Japan Tourette Syndrome Drug Sales Market Share by Application in 2020
Figure 45. Southeast Asia Tourette Syndrome Drug Sales Market Share by Type in 2020
Figure 46. Southeast Asia Tourette Syndrome Drug Sales Market Share by Application in 2020
Figure 47. India Tourette Syndrome Drug Sales Market Share by Type in 2020
Figure 48. India Tourette Syndrome Drug Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Tourette Syndrome Drug
Figure 51. Manufacturing Process Analysis of Tourette Syndrome Drug
Figure 52. Tourette Syndrome Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed